BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.18.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20260101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270112
DTEND;VALUE=DATE:20270115
DTSTAMP:20261007T105217Z
CREATED:20261007T105217Z
LAST-MODIFIED:20261007T105217Z
UID:44495-1799712000-1799971199@www.pharmajournalist.com
SUMMARY:PFS & Injectable Drug Devices Europe
DESCRIPTION:PFS & Injectable Drug Devices Europe 2027 will bring together pharmaceutical\, biotechnology\, medical device and drug delivery professionals in London from 12–14 January 2027 to explore the latest innovations in pre-filled syringes\, injectable drug delivery devices\, combination products and primary packaging. \nNow in its 19th year\, the conference will provide a focused platform for industry leaders to discuss the technologies\, regulatory developments and market trends shaping the future of injectable drug delivery. The event is designed for professionals working across pharmaceutical development\, drug-device combination products\, medical devices\, pre-filled syringes\, primary packaging\, human factors\, regulatory affairs and manufacturing. \nThe three-day programme will feature presentations and discussions from experts across the pharmaceutical and biotechnology sectors. Key topics will include next-generation pre-filled syringe technologies\, large-volume drug delivery\, novel injectable delivery systems\, device development\, quality by design\, design controls\, human factors and patient-centric drug delivery. \nRegulatory and compliance considerations will also be a major focus\, with sessions exploring combination product regulations\, Article 117\, notified body requirements and evolving European regulatory expectations. These discussions will help companies understand the changing requirements for developing and commercialising injectable drug-device products in Europe. \nThe conference will also examine the growing importance of sustainability in pharmaceutical packaging and drug delivery devices\, including circular economy approaches\, lifecycle carbon assessment and sustainable packaging strategies. \nWith 250+ attendees\, 50+ expert speakers\, interactive roundtables and dedicated networking opportunities\, PFS & Injectable Drug Devices Europe 2027 offers pharmaceutical and biotech professionals an opportunity to share knowledge\, discover new technologies and connect with senior industry decision-makers. \nThe event is particularly relevant for professionals involved in pre-filled syringes\, injectable drug delivery\, combination products\, medical device development\, primary packaging\, pharmaceutical manufacturing\, regulatory affairs and human factors engineering. \nFor more information about the event\, Click Here.
URL:https://www.pharmajournalist.com/event/pfs-injectable-drug-devices-europe/
LOCATION:Marriott Hotel Grosvenor Square\, 10-13 Grosvenor Sq\, London\, W1K 6JP\, United Kingdom
ORGANIZER;CN="SAE Media Group":MAILTO:Alessandra.DeMaria@saemediagroup.com
END:VEVENT
END:VCALENDAR